معرفی
Mario Parra Rodriguez is a Professor in the Department of Psychology at the University of Strathclyde, United Kingdom. He is actively engaged in research, supervision, and international academic collaboration, with a focus on cognitive neuroscience and dementia. He is accepting PhD students and has a strong presence in global brain health initiatives.
- University: University of Strathclyde
- School: Faculty of Humanities and Social Sciences
- Department: Department of Psychology
- Academic Rank: Professor
His research centers on Alzheimer's disease, memory assessment, EEG biomarkers, and the application of virtual reality and remote technologies in cognitive evaluation. He investigates the continuum from normal aging to dementia, aiming to develop affordable, scalable, and multimodal neurocognitive tools for early detection.
The recent articles reflect a strong trend toward digital and technology-driven approaches in dementia research. Themes include EEG-based biomarkers, virtual reality assessments, remote cognitive testing, and international cohort studies. His work bridges clinical neuropsychology with cutting-edge technology, emphasizing real-world applicability and global health equity.
Scientific awards include recognition from the Latin American and Caribbean Consortium on Dementia (LAC-CD), Global Brain Health Institute (GBHI), and multiple honors for innovation in cognitive assessment and neurocognitive biomarkers. These reflect his international impact and leadership in the field.
Mario Parra Rodriguez has supervised PhD students and research projects, with 39 funded projects and extensive academic activities including invited talks, conference organization, and editorial roles. His work is supported by international collaborations and grants focused on brain health, aging, and dementia prevention.
He is involved in key networks such as the LAC-CD and GBHI, and collaborates with institutions in Colombia, Ireland, and beyond. His lab and team focus on developing and validating novel cognitive paradigms and digital tools for neurodegenerative disease detection and intervention.
